Severe neuroleptic malignant syndrome: Successful treatment with high-dose lorazepam and diazepam: A case report

Chang Gung Medical Journal

Volumn 33, Issue 5, 2010, Pages 576-580

  Tsai, Meng Chang ^a   Huang, Tiao Lai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Diazepam; Lorazepam; Neuroleptic malignant syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BIPERIDEN; CREATINE KINASE; DIAZEPAM; FLURAZEPAM; HALOPERIDOL; LORAZEPAM; MYOGLOBIN; OLANZAPINE; PARACETAMOL; VALPROIC ACID;

ABNORMAL LABORATORY RESULT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIPOLAR I DISORDER; BIPOLAR MANIA; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DELIRIUM; DELUSION; DIAPHORESIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG FEVER; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEVER; FLUID THERAPY; FOLLOW UP; FRANCIS YACOUB NEUROLEPTIC MALIGNANT SYNDROME RATING SCALE; HUMAN; HYPERACTIVITY; HYPERTENSION; KIDNEY FAILURE; MALE; MOOD DISORDER; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PROTEIN BLOOD LEVEL; PSYCHOSIS; RATING SCALE; RHABDOMYOLYSIS; SIDE EFFECT; SLEEP DISORDER; TACHYCARDIA; TAIWAN;

DIAZEPAM; DRUG THERAPY, COMBINATION; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 78249289373     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Adityanjee, Sajatovic M, Munshi KR. Neuropsychiatric sequelae of neuroleptic malignant syndrome. Clin Neuropharmacol 2005;28:197-204.
2. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185-202.
3. Spivak B, Maline DI, Vered Y, Kozyrev VN, Mester R, Neduva SA, Ravilov RS, Graff E, Weizman A. Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome. Acta Psychiatr Scand 2000;102:226-30.
4. Yacoub A, Francis A. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Neuropsychiatr Dis Treat 2006;2:235-40.
5. Francis A, Chandragiri S, Rizivi S, Koch M, Petrides G. Is lorazepam a treatment of neuroleptic malignant syndrome? CNS Spectr 2000;5:54-7.
6. Stubner S, Rustenbeck E, Grohmann R, Wagner G, Engel R, Neundorfer G, Moller HJ, Hippius H, Ruther E. Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry 2004;37 suppl 1:S54-64.
7. Panagariya A, Sharma B, Singh R, Agarwal V, Dev A. The neuroleptic malignant syndrome: A report of 14 cases from North India. Neurol India 2007;55:166-8.
8. Woodbury MM, Woodbury MA. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry 1992;31:1161-4.
9. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164:870-6.
10. Kumar V. A case of neuroleptic malignant syndrome treated with diazepam. Can J Psychiatry 1987;32:815-6.
11. Lew TY, Tollefson G. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol Psychiatry 1983;18:1441-6.
12. Nisijima K, Ishiguro T. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiatr Res 1995;29:233-44.
13. Huang TL. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005;59:52-5.
14. Tan W, Herzlich BC, Funaro R. Rhabdomyolysis and myoglobinuric acute renal failure associated with classic heat stroke. South Med J 1995;88:1065-8.
15. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998;49:1163-72.
16. Diedler J, Mellado P, Veltkamp R. Endovascular cooling in a patient with neuroleptic malignant syndrome. J Neurol Sci 2008;264:163-5.
17. Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 1998;44:499-507.